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Pediatric Liver Transplantation 
With Cyclosporine and Steroids 
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i\lthou!!h tht' first liVl'r transplanl in a human was perfonnt'd in 11J6,l, it was 
flot Ulllil J"lv 11,167 thai Ihe firsl lon/!-tenn survivor received a transplant. Or 
., homa, Stalll wlTessfuily franspl~1f11ed a liver into'lII IX-month-old girl with 
a hepatollla Sht' ~urvived I,l monlhs hefore succumhin!! tn fllt~taDtases of her 
on)!inal dist';I\l' I horn 11J6,1 unlil 11J79, 170 palienls were tr:lI1splanled hy Dr 
Startl in ('"lorado, induding X6 pediatric patients," ('onventional illlmuno-
.. uppre .... ioll was used, From May IIJX I until May '9X;\, 47 additi(lflalchildren 
[t'rcivl'd olthotoptl' liver transplants at Children's Hospital of Pillsnurgh under 
Ilr Slarti. lf"n~ l"vd .... pllrine <lntl "Deroill~D This report sUlllmari/l's the t'Jl.pe-
rienre 01 th .. ,t' ..J 7 patients, 
1 1 , 
.. 
Patient Selection 
Afler initial ((milict with Ihe family or the referring physici<ln, we received 
records of the plltient"s course, including biopsy material, for review. A brief 
ho1ipital evaluation was then arranged to I) confirm the diagn(lsis, 2) evaluate 
Ihe severity of liver disease, .1) assure appropriate anatomy for transplant, and 
4) provide educlltion and suppm1 10 thc family. 
Childrcn considered for transplantation generally weighed 7 kg or more, 
Those wilh hiliary alresia wcre considcred if hcpatoportoentcrostomy had failcd 
or if hepatic decompenslition existed. Children wilh disorden; of uncertain prog-
nosis were considered activc candidates when progressive hepatic decompen-
sation occurred. 
I rn rnunosuppression 
No systematic allempt al homEllo~ous leukocYlic antibody (HLAI matchin/! of 
donor and recipicnt was dOlle, The slime general guidelincs for hlooJ Iransfu-
sions were used. A80 Iypc-spel'ific organs were usually used for transplanl, 
because of Ihe maximum cold ischcmic time of 12 hours thlll can he suhjccted 
upon the harvcsted organ. In addition, the livcr appears to he resistant to 
hyperacule rejeclion, as seen in renal transplants.' 
Cyclosporinc, a fungal extraci wilh powerful immunosupprcssivc properties 
and minimal hone marrow toxicity, was administered to every patient imme-
diately beforc surgcry" Oral cydosporine was continued posloperalively until 
bilirubin and trallsaminascs normali7.ed. At that point, intravenous cyclosporine 
was tapered rapidly and discontinued. A bursl of steroid was lIliministereJ in 
the immediatc postoperative period lind rapidly tapered over."i days to a hllseline 
of 5 to 20 f11/! daily. 
Results 
In thc 24-f11onth period fmlll May 191(1 to May IIJXJ, 47 children ranging in 
age from 7.."i months to IX years received transplants, The smallestl'hild weighed 
7 kg. There were 20 males and 27 femalcs. Thirty patients (64%) arc surviving. 
Table I lists the lliagnoses lIml outcome. 
Sixty-four grafts were used in the 47 patients. Fifteen patients (J2'}'t') required 
retransplantalion. Thirteen patienls received two grafts and IWO paticnts 
received three /!mfts. Seven of Ihe 15 patients (47%) with relransplants are 
surviving. Of the 64 grafts used, JH (59%) survivcd or functioned normally at 
the lime of the patient's death. Causes (If graft failure included rejection (ll), 
massive infarclion with palt'nt vessels (X), vascular accidt'nls or thmrnhoses 
(5), and infection (5). 
Infection continues 10 he a major causc of I1lllfhidily and mortality. hut is 
less serious than during the prccyclosporinc era. Before the usc 01 l'ydosporine, 
hacteremia and/or fUIl/!emia occurred with 70% of thc grafts used.' In our 
experiencc, baclcremia (45')0 and fungemia (6%) occurrcd with only 51 'lI. of 
the grafts used, In thc 47 patients receiving Iransplanls in Piltsnlll'/!h, entcric 
nrganisms predominated among thc episodes of hacleremia. Enterococcus was 
the organism most frequently l'ultured frnm Ihe hlood, wilh 1:'.\'/"'1';"";11 ("01; 
and Pst'tIt/om(lnaJ also seen. SllIl'hyl(/('(/ccu.{ tl/lrl'IH was uSlililly l'ullureu in 
relation to line-related nacteremia, ('tit/did" species often ollltarnlllat,'" W(lllIllls 
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Blliaryatre\ia 
I\klaht.lil"l'IlOditions 
n, .. Antitrypsin defil'iency 
( ilyco!!en stllra~lD disease I 
I krcditary tyrosinemia 
Wilson's di .. l'asc 
Sea-hlue histiocyte syndrome 
BIliary hypoplasia 
( 'hronil' activl' hepatitis 
bmilial chlliestasis 
Nconatal hepatitis 
Biliary nhstnll'lion 
fklli~n liver tumor 
'tll'alhs 
R 
I 
I 
2 
I 
19 (7). 
U 0) 
3 (2) 
4 (2) 
5(2) 
I 
I (I) 
I 
47 (17) 
ami wa~ rt'iatcd 10 repeated hiliary-tract surgery. ('ytOllll'galovirus has been 
Clllturl'd I rom urine. liver. and lung. and at least one graft was lost due to 
adentlvlru~ infection. 
()thl'r l'tlfnplications were numerous, and those oCl'urrin!! in the survivors 
arc slIlIIlIlari/ed in Tahle 2.' Two months served as a convenient marker for 
early,,,,,, latl' complications, since most patients were disdlarged fmm the 
hll~pital at appmximately that time. Hypertensi(ln was virtually universal in 
~urvivor~K and generally responded to captopriL Rejection episodes occurred 
in Illore than two thirds of the survivors and was corrected with increased 
illlmun""uppression. Portal vein or hepatic artery thrombosis occurred in three 
patienh, necessitating retransplantation .. Latc complications still included 
rejection as a major event. In addition, interstitial pneumonitis due to mn~u­
m(ln's/i.\ ,'"r;n;; was seen in two patients. One patient developed intestinal 
l.hst·flll'IIOn from a Iymphopmliferative dis:lfder approximately 6 months post-
tran~lDlanl This coindded with an acute rise in his Epstein-Barr virus (EBV) 
titer. The tumor wa~ partially resected. and treatment nmsisted only or dras- I 
lit'allv reducinJ;! the immunosuppressive regimen. Although the palienl 
til"vl'ltllll'tichronic rejection, he has had no evidcnce of tumor rccurrence I year 
aflrf fllllUlr resection. Increased immunosuppression has alltlwed hetler control 
III' t hI' rdl'ct illn. 
Thirtn'n children with various metabolic diseases received transplants. Eighl 
children had fY,-antitrypsin deficiency. In all children in whom measured. 
n, ·antltrypsin levels became normal and the recipients assumed thc protease 
inhihilClf ,Pi, type of Ihe dOllor. There has ocen 110 evidenct' of regression or 
rel'llrrencc (If the disease to Ilate.'·' The child with type 1 glycogen storage 
dfyEDa~e t{'4uired fre4uent daytime feedinJ;!s and continuous nudumal feeding. 
heft.re lransplant.. She ret'eived a transplant because of hepatit' adenomata and 
pnlgressive hepatic failure. Carbohydrate hlllleo~tasis 6 weeks postoperatively 
was normal, with the ahility tIl withstand a 24-hour fasl and hrisk !!Iycogenolysi. 
in responsl' 10 gltlCa!!IIn .. • The patient with hereditary tyrosinemia was on • 
1J4 j 
Table 1, Number" Survlyon Experlendq MYw Complication •• 
Early « 2 months) Late(> 2monlhs) 
Hypertension 29 Rejection 7 
(Sei7.Ures: ~F (Chronic: I) 
Rejection 21 Portal vein ohstruction 4 
Life-threatening infection R Biliary anastomosis surgery 2 
Biliary anastlllllosis surgery 5 Hypertension 2 
Tracheustomy 4 Interstitial pneumonia 2 
Vascular thrombosis Lymphoproliferative disorder I 
(retransplant) J Pseudotumor cerebri I 
Transient diabetes mcllitus 2 Recurrent metaholic disease I 
markedly restricted diet pretransplant and had developed a hepatoma. After 
successful hepatic transplantation. she maintained normal serum amino acids 
on a regular diet and has had no evidence of tumor recurrence. One of two 
patients who received transplants because of Wilson's disease survived, and has 
had normalization of serum ceruloplasmin and copper. has maintained normal 
hepatic copper, and has had inl'reased urinary copper levels. In addition. centml 
nervous system abnormalities consistent with Wilson's disease reversed over 
the 6 to 12 months posllransplant. The child with the sea-hlue histiocyte syn-
drome had progressive neurologic deterioration, cirrhosis. and hepatoma .. 
Despite successful hepatic transplantation and transient plaleau of neurologic 
function, she has had recurrence of ceroid-like materials in thc Kupffer cells 
of the transplanted liver and continued neurologic regression.' 
Status of the JO survivors as or May 1983 is listed in Tahle J. Follow-up of 
these patients ranged from 5 to 2R months. All patients were clinically well. 
The average prednisone dose was 5 mg per day, or approximately {U mg/kg 
per day .. The mean cyclosporine dose was 15 mg/kg per day .. 
Outcome 
Excellent 
Good 
Fair 
No, 
27 
2 
I 
Bilirubin 
(mgldL) 
0.2-1.1 
0 .. 7-1.3 
3.11 
Alanine 
Aminotransferase 
(llJlmL) 
12-100 
1L'-170 
RQ 
Linear growth was monitored before and after transplant. Twenty-four of the 
30 survivors had !leen followed at least 6 months to ohtain adequate growth 
data. 1 Two patients were mature at the time of transplant. Of the remaining 22 
patients. all hut J either exhihited accelerated growth velocity with catch-up 
growth or maintained normal growth velocity. The patient with the sea-blue 
histiocyte syndrome had no growth in the follow-up period. due to the use of 
high-dose steroid therapy to reverse rejection as well as possihle recurrence of 
her original disease. 
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Conclusions 
Orthlllopic livcr transplantation with cydEl~spor~:Ie and sEteFDvrEeDirgaltlh~::~~::le~~~~~ 
h'ld 'th nd-stage Iver ulsease, , ' 
livc Ihcrapy fEF~ I.' I ren WI e .' rine as well as with improved surgical 
haw douhled With the advcnt (If cYd.o.spo 'I' '( '" uf "raft failure and 
. d di(:al ('are In additIon, ear y recoglll II '" , le":1~14rt" >a~tr;:::plantationD have contribuied to improved palien! survival.. 
a!!!!rC\"IVC I' . is a potent immunosuppressant, ils marrow-spanng 
Al1ht.ugh eye osponne , . . ,.Ies of h'lcteremia and fungemia. This. h h . . ntrihuted to fewer epls(1\J ' , . I ~K ,nader as (:(1 ., d urvival Whik enleric and lunga I I n a major faclor In Improve s , 
tou. las ICe , '. I ()7.oal and vim I infcl'lillns wilh Pnt'u-
inkeliono,; r("mam sen I (IUS glrohle~l:d:~:f~i;rp .:Iso reprt'senl pOlentially life-
mOl'n/H, cytomega OVlfUS, an< 
thrcalcllillJ! d,iseases. ,I' " but one survivor and llIay he related to cyclo-
IfYIICrten\lon on:urreu III a , , . k '1 may 
. • hou h the mechanism of the hypertension IS Ull nown: I . 
spoflnc lI .. e, All g, . . 1m'" The Iymphoprolifcratlve diS-tIC lIlediated via Ihe renlll-anll-,otensIO sys e, '. . I t 
' . ' h FRV infeclion, as desnlhl.'d wllh other transp an 
order appears to ()(;cur w.'11 ' t of Ihcse 1)'Ilients lIIay involve nol 
., to,; " The successfu manage men '. h 
pallt n , , . , ' n further with cht'lllolherapy, hut rat er 
immunosuppress",/;! the r.lt:en,tv: :eoimen to allow natural IHlst defenses 10 Itlwerlllg Ihe IInmUlle surpr( ""I ... 
,'omllal the EHV inl.ection. ". . I unit hI intervene in meta/x)lic 
I iWI trolllsplantalllln pnwldes a umque op!", rt y.. , ded 
. . 'I I thai While transplanlalHlIlls nol recommen tlio,;ortlt'r\ Ihat prevIous y were e ' 
as primary therotJlY for type I glyco/o!en stonl/o!e disease :lIId Wilson's diseasl', il 
relllilins another option for potential I.'ure when medical Ihempy rails. 
Liver transplantation in dlildren remains a (:hallengin!! and demanding pro-
ccdurc, hUI thc survival rate is l'onsluntly improving. Improvement in lifeslyle 
is uniform. PSYI.'hosot.:ial issues have heen monitored dose/y, and preliminary 
data suggest considerable improvement in physical, lan!!uage, and gross molnr 
function. Children unahle to participate in school before the transplanl arc now 
partiCipating on a regular basis. In addition, improvemenl in health allowed 
lifting of reslrit:tiuns to permit age-appropriate aclivilies." Hecause children 
offen have newliluml energy and hecome impulsive, parents s(}Illetillles require counselin~ 10 deal with the "loss" of a placid, docile, ill dlild and the sudd,'n 
acquisition of an aclive, ramhunctious one. 
~ Overall, orthotopic liver transplantation represents a major advancement in 
the therapy of end-stage liver disease. 
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Discussion 
DR ANDERSEN: What do you Ihink causes Ihe hypertension pmlllerns in 
transplants" fK~ il cydo"porine? 
DR ZITELU: I helieve thaI cyd(Js!",lrine is related, hUI I alii nol sure of the 
Ua<:t mechanism. " may !le mediated thmugh the angilliensin system, We have 
round thatcaptopril is the !lesl a~cnt for controlling hypertension. 
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DR VAN THIEL: In heart transplants in adults. cyclosporine dramatic;IlIy 
increa .. es peripheral resistance. ('aplopril seems to be the only drug that touches 
the hypcnension, Vascular vlllunlt: and cardiac output remain stahle. ('yelo-
sporine seems to affect peripheral vessels. 
DR WUlTINGTON: We have treated several children with propranolol. We 
just titrated them until we gol a reduction in the heart rate. 
DR ZITELLI: We also have used propranolol. hut have found that many children 
will maintain hypertension despite large doses. 
DR POLEY: How would you rate the potential risk for the development of 
mm-A. non-B hepatitis after so many hlood transfusions? 
DR VAN THIEL: It is prohahly appropriate for me to talk about it because 
children receive SOOO mL as tht' upper limit of transfusion, which is a pitifully 
small amount of hluod in adults. The average liver transplant in adults requires 
ahout40 units (If bhxxl. We have used as much as I flO units of hl(xxl in a single 
transplant. and the record in the United Stlltes is 26K units. To my knowledge. 
flO one has ever made the diagntlsis of non-A. non-B hepatitis after :1 liver 
transplant, and that tells you that things are so hectic in those first J Illonths 
that it's impossihle tn nmke that dia!!llosis until a serologic marker is availahle. 
DR ERUNGFR: We were told hcfore that in children with biliary atresia, 
transplantation was considered only when the earlier operation failed. Is Ihat 
still the policy'! 
DR ZITELLI: Yes. when the Kasai procedure has failed or the patient develops 
other life-threatening progressive hepatic decompensation. 
[)R VAN THIEL: In a comp!lrahle disease in adults, sclerosing cholangitis. in 
which many of these same m<IOipulations in the porta hepatis occur. prior sur-
gery clearly extracts a cost in survivorship as a result of liver transplantation. 
In fact, sclerosing cholan!!itis earries the worst prognosis for survival in an adult 
who is to have a liver transplant This is hccause of the multiple surgical pro-
cedures in the porta hepatis. sepsis related 10 those operations. and the massive 
l'ollalerals that develop in the adhesions in and around the pona hepatis. 
DR AlTMAN; The Kasai pron'durc l'ertllinly will stand or fall on its own 
merits. But extrapolating frt)fJl sdemsing cholangitis to biliary atresia in chil· 
dren is imprecise. and the Kasai operation will relieve jaundice and allow growth 
and development in certain patients. 
[)R ZITELLI: J think Ihe prohlcrn of transplantation in biliary atresia is such 
that we have not yet reat:hed the stage of recommending liver transplantation 
as a primary IJI(xie of sur!!ical Ihl'rapy for hiliary atresia. 
[)R HlISTAMANTE: Given the number of patients who can be helped hy thi~ 
pmcedure. how do you .iustify cost'! . 
[)R ZITELLI: That is very difficult. particularly with children. We would hke 
to determine whether liver tran~plantationI despite the tremendous cost. is in 
fact a cheaper way to handle chronic liver disease than trying to support the 
patient over a peri(xI of time ami ultimately have the patient die. We know. for 
example, that hospital treatment f(lr gastrointestinal bleeding may cost $SO.O()() 
and the patients often have rept.'ated gastrointestinal hemorrhages. We are com-
paring pretransplant and JlI,sttransplant costs to see if it is less expensive to 
perfonn transplants in thl''ie patients. 
\ 
Management of Neonatal Cholestasis 
A Summary 
\ Philip Sunshine, MD 
During !his conference, we reviewed the various factors th .. t relate II 
and focu~d on those that occur primarily in the neonatal period. 
The mai\>r problem that currently confronts physicians caring 
appears to be that of cholestasis associated with the use of parentel 
While this fo~ of nutritional support is paramount for the surviv 
with gas!mint~stinal catastrophes, malformations. Of immatufe t 
approach to sol~gng the complication of cholestasis has continued 
even though we have devoted a great deal of time and effort to the \II 
of this entity. In patients who require total parenteral nutrition (TPr 
than 2 weeks, the incidence of cholestasis begins to increase signil 
in some cases, even 'though the TPN is discontinued. patients go (' 
chronic liver disease 'and liver failure,' Apparently. manyetiolog' 
involved in producing~his entity, and these have !leen addressed" 
The various factors th~ have !leen incriminated in the devclopn 
associated cholestasis are listed in Tahle I. 
. lIb1e I. cKaorsqlult~ay Belnyolved In the DevelOpmell 
: .. PareDteni Nutrltloa ~kF-AK .. oelated Cbolestasis. 
.I • 1 ,'" " ~K ':. "". , f I, _ ; '.;. I~1 . 
Immature hepatic synthesis \If "ile acids 
Immature hepatic excretory r"nction 
Elaboration of aberrant hile at\ids 
Lack of enteral stimulation 
Decreased activity of 1!3stftlinte\tinal honnones 
Adverse effect of amino at· ids ol\their metaholites on canaliculi" 
Amino acid imbalan<:e \ 
Decreased concentration (If cenain'.amino arids (cvsteine. taurin ! 
Omtical'iduria \. i 
Sepsis \ 
Cholangitis \ 
Decreased concentration of fat-so/uhle\ vitamins 
Increased concentrations (If copper in f~ver 
Agents that interfere with s(xlium-coupl d ion transport (furose, 
Blitzer1 ' has illustrated the effects of v inus amino acids (' 
uptake in isolated rat hepatocytes and also .referred to the en 
inhibitors of the sodium-coupled ion transp<);:i\of bile acid upta 
cll-workers· have demonstrated, at least in la atory animals, 
and p<)ssibly tryptophan metaholites are major cu prits in initiati 
picture. In addition. we are encountering an incre sing number 
cholelithiasis who are receiving TPN. and possib the same I 
to the production of gallstones are involved in the oduction ( 
Similarly, patients with cystic fibrosis who require\ TPN dey· 
\ 
readily, illustrating that secretion of hi Ie acids can b( altered' 
sEFdium-depende~t pumps are not operating well. 
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